Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2016 (2016), Article ID 4832543, 8 pages
http://dx.doi.org/10.1155/2016/4832543
Research Article

Association of Serum CXCL13 with Intrarenal Ectopic Lymphoid Tissue Formation in Lupus Nephritis

1Department of Rheumatology and Immunology, Pingxiang People’s Hospital, Pingxiang, Jiangxi 337055, China
2Department of Infective Diseases, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China
3Department of Rheumatology and Immunology, Panyu People’s Hospital, Guangzhou 510080, China
4Department of Rheumatology and Immunology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China

Received 30 June 2016; Revised 31 August 2016; Accepted 6 September 2016

Academic Editor: Guixiu Shi

Copyright © 2016 De Ning He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Liu and H.-J. Anders, “Lupus nephritis: from pathogenesis to targets for biologic treatment,” Nephron Clinical Practice, vol. 128, no. 3-4, pp. 224–231, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Lech and H.-J. Anders, “The pathogenesis of lupus nephritis,” Journal of the American Society of Nephrology, vol. 24, no. 9, pp. 1357–1366, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Sanz, “Rationale for B cell targeting in SLE,” Seminars in Immunopathology, vol. 36, no. 3, pp. 365–375, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Sang, Y.-Y. Zheng, and L. Morel, “Contributions of B cells to lupus pathogenesis,” Molecular Immunology, vol. 62, no. 2, pp. 329–338, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. G. F. Dong, X. Zhang, D. N. He, L. Li, and G. F. Zhang, “Effect of leflunomide on the abnormal expression of lipid rafts and F-actin in B lymphocytes from patients with systemic lupus erythematosus,” Journal of Immunology Research, vol. 2015, Article ID 832916, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. O. T. M. Chan, L. G. Hannum, A. M. Haberman, M. P. Madaio, and M. J. Shlomchik, “A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus,” Journal of Experimental Medicine, vol. 189, no. 10, pp. 1639–1647, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Pitzalis, G. W. Jones, M. Bombardieri, and S. A. Jones, “Ectopic lymphoid-like structures in infection, cancer and autoimmunity,” Nature Reviews Immunology, vol. 14, no. 7, pp. 447–462, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Wu, J. Guo, R. Ding, B. Lv, and L. Bi, “CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice,” Acta Histochemica, vol. 117, no. 8, pp. 732–737, 2015. View at Publisher · View at Google Scholar
  9. L. Schiffer, K. Worthmann, H. Haller, and M. Schiffer, “CXCL13 as a new biomarker of systemic lupus erythematosus and lupus nephritis—from bench to bedside?” Clinical and Experimental Immunology, vol. 179, no. 1, pp. 85–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, pp. 1725–1732, 1997. View at Google Scholar · View at Scopus
  11. K. M. Corapi, M. A. Dooley, and W. F. Pendergraft III, “Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials,” Arthritis Research and Therapy, vol. 17, no. 1, pp. 110–117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. J. J. Weening, V. D. D'Agati, M. M. Schwartz et al., “The classification of glomerulonephritis in systemic lupus erythematosus revisited,” Journal of the American Society of Nephrology, vol. 15, no. 2, pp. 241–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. O. M. Steinmetz, J. Velden, U. Kneissler et al., “Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis,” Kidney International, vol. 74, no. 4, pp. 448–457, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Cheng, I. M. Mumtaz, L. Khodadadi, A. Radbruch, B. F. Hoyer, and F. Hiepe, “Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis,” Annals of the Rheumatic Diseases, vol. 72, no. 12, pp. 2011–2017, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. T. F. Imran, F. Yick, S. Verma et al., “Lupus nephritis: an update,” Clinical and Experimental Nephrology, vol. 20, no. 1, pp. 1–13, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. C. D. Cohen, N. Calvaresi, S. Armelloni et al., “CD20-positive infiltrates in human membranous glomerulonephritis,” Journal of Nephrology, vol. 18, no. 3, pp. 328–333, 2005. View at Google Scholar · View at Scopus
  17. H. L. Martins, C. Silva, D. Martini, and I. L. Noronha, “Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens,” Transplantation Proceedings, vol. 39, no. 2, pp. 432–434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. O. M. Steinmetz, U. Panzer, U. Kneissler et al., “BCA-1/CXCL13 expression is associated with CXCR5-positive B-cell cluster formation in acute renal transplant rejection,” Kidney International, vol. 67, no. 4, pp. 1616–1621, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Angeli, F. Ginhoux, J. Llodrà et al., “B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization,” Immunity, vol. 24, no. 2, pp. 203–215, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Blüml, K. McKeever, R. Ettinger, J. Smolen, and R. Herbst, “B-cell targeted therapeutics in clinical development,” Arthritis Research & Therapy, vol. 15, supplement 1, article S4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. C. C. Mok, “Current role of rituximab in systemic lupus erythematosus,” International Journal of Rheumatic Diseases, vol. 18, no. 2, pp. 154–163, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Beckwith and L. Lightstone, “Rituximab in systemic lupus erythematosus and lupus nephritis,” Nephron-Clinical Practice, vol. 128, no. 3-4, pp. 250–254, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Shen, C.-Y. Sun, F.-X. Wu et al., “Association of intrarenal B-Cell infiltrates with clinical outcome in lupus nephritis: a study of 192 cases,” Clinical and Developmental Immunology, vol. 2012, Article ID 967584, 7 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Chang, S. G. Henderson, D. Brandt et al., “In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis,” Journal of Immunology, vol. 186, no. 3, pp. 1849–1860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Klimatcheva, T. Pandina, C. Reilly et al., “CXCL13 antibody for the treatment of autoimmune disorders,” BMC Immunology, vol. 16, no. 1, article 68, 2015. View at Publisher · View at Google Scholar · View at Scopus